UCSD Eye Doctor Resigns After Investigation into Ties with China

The FDA and the university have audited Kang Zhang for breaches in bioethics and a failure to follow research protocols.

Written byNicoletta Lanese
| 4 min read
zhang

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Prominent University of California, San Diego, eye doctor Kang Zhang resigned on July 4 after inewsource raised questions about his financial and political ties with China.

The publication uncovered that Zhang is a member of the Thousand Talents Program, a recruitment initiative that “incentivizes scientists to illegally take intellectual property developed at U.S. universities to China,” according to the FBI. inewsource also found that Zhang was involved in testing a controversial new surgical treatment for infants with cataracts in China, and that the doctor failed to disclose to UCSD and the federal government that he is a cofounder and primary shareholder of a Chinese biotechnology company.

Zhang founded UCSD’s Institute for Genomic Medicine in 2009 and served as the university medical center’s chief of eye genetics. He joined the Thousand Talents Program in 2010 and cofounded his company CalCyte Therapeutics in the same year. Zhang never mentioned the company in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo
Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery